Results 281 to 290 of about 4,200,228 (359)

Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial (PACIFIC)

Epilepsia, EarlyView.
Abstract Objective This randomized, double‐blind, phase 1b/2a clinical trial was designed to evaluate the safety, tolerability, and efficacy of oral bexicaserin versus placebo for the treatment of seizures in adolescents and adults with developmental and epileptic encephalopathies (DEEs).
Dennis J. Dlugos, Ingrid E. Scheffer, Jacqueline A. French, David G. Vossler, Chad Orevillo, Shikha Polega, Randall Kaye, and the LP352‐201 Study Investigators, Kore Liow, Ena Zhu, Jennifer Waldron, Hayley Groubert, Alexis Anderson, Pavel Klein, Salman Hashmi, Shicong Ye, Anita Farhi, David Vossler, Dione M. Froman, Shannon L. Hoffman‐Huffaker, Ki Hyeong Lee, AnnaLyn Dallas, Amir Arain, Laura Beeler, Michael Macken, Irena Bellinski, Elizabeth Cunningham, James Renfroe, Shezsay Colbert, Robert Hogan, Patty Schaefer, Susan Shaw, Sheetal Desai, Ahmed Sadek, Haile Robertson, Kamil Detyniecki, Anabela Cieslicki, Ruben Kuzniecky, Sarah Goodman, Selim Benbadis, Marina Azevedo, Sami Aboumatar, Julie Biel, Nilika Singhal, Emerald Wan, Evan Fertig, Hannah Hart, Debopam Samanta, Sarah Hankins, Steven Wolf, Patricia Pena, Robert Nahouraii, M. J. Mari, David Burdette, Stephanie Mueller, Karen Keough, Victoria Henderson, Talitha Durgin, Terence O’Brien, Rafael Smith, Jack Germaine, Kate Riney, Lori Anthony, David Reutens, Kimberley Irwin, Michael Fahey, Melissa Batt, Stephanie Kaladis, Kasthoori Jeyachanthiran, Ingrid Scheffer, Rebecca Wharrie, Greesha Zacharia, Brittany Walsh, Heather Robinson, Sharon Ganter   +74 more
wiley   +1 more source

France forgets own golden age of medical marijuana

, 2019
David Jr.
openalex   +1 more source

Provider Perspectives on Use of Medical Marijuana in Children With Cancer

Pediatrics, 2018
Prasanna Ananth, Clement Ma, Hasan Al-Sayegh, Leah Kroon, Victoria Klein, Claire M. Wharton, Elise Hallez, I. Braun, K. Michelson, A. Rosenberg, W. London, J. Wolfe   +11 more
semanticscholar   +1 more source

Headache in individuals undergoing hormone therapy for gender transition: A cross‐sectional, observational study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the prevalence, frequency, and characteristics of headache disorders in transgender individuals receiving gender‐affirming hormone therapy (GAHT), and to explore the relationship between GAHT and headache pathophysiology.
Lucia Jimena Zavala, Andreina Gil Ramirez, Kjersti Grøtta Vetvik, Rigmor Højland Jensen, Anders Hougaard   +4 more
wiley   +1 more source

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani, Larry Charleston IV, Shannon Strom, Detlef Albrecht, Robert Cowan   +4 more
wiley   +1 more source

State of the States: New York and California push sanctuary policies, Flint’s water bill subsidy ends, and North Dakota’s medical marijuana ballot that wasn’t: 4 – 10 February [PDF]

, 2017
Chris Gilson
openalex  

Patients, Police, and Care Providers: The Cultural Dimension of Medical Marijuana Implementation

, 2011
Michael Hammer
openalex   +1 more source